US Lawyer Database

For Lawyer-Seekers

YOU DESERVE THE BEST LAWYER

Home » US Law » 2022 Rhode Island General Laws » Title 23 - Health and Safety » Chapter 23-6.4 - Life-Saving Allergy Medication — Stock Supply of Epinephrine Auto-Injectors — Emergency Administration

Section 23-6.4-1. – Definitions.

§ 23-6.4-1. Definitions. As used in this chapter: (1) “Administer” means the direct application of an epinephrine auto-injector to the body of an individual. (2) “Authorized entity” means any entity or organization at, or in connection with, where allergens capable of causing anaphylaxis may be present, as identified by the department of health. The department […]

Section 23-6.4-2. – Prescribing to an authorized entity permitted.

§ 23-6.4-2. Prescribing to an authorized entity permitted. An authorized healthcare provider may prescribe epinephrine auto-injectors in the name of an authorized entity for use in accordance with this section, and pharmacists may dispense epinephrine auto-injectors pursuant to a prescription issued in the name of an authorized entity. History of Section.P.L. 2014, ch. 514, § […]

Section 23-6.4-3. – Designated entities permitted to maintain supply.

§ 23-6.4-3. Designated entities permitted to maintain supply. An authorized entity may acquire and stock a supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this chapter. Such epinephrine auto-injectors shall be stored in a location readily accessible in an emergency and in accordance with the epinephrine auto-injector’s instructions for use and […]

Section 23-6.4-4. – Use of epinephrine auto-injectors.

§ 23-6.4-4. Use of epinephrine auto-injectors. An employee or agent of an authorized entity, or other individual, who has completed the training required by § 23-6.4-6, may, on the premises of or in connection with the authorized entity, use epinephrine auto-injectors prescribed pursuant to § 23-6.4-2 to: (1) Provide an epinephrine auto-injector to any individual […]

Section 23-6.4-5. – Expanded availability.

§ 23-6.4-5. Expanded availability. An authorized entity that acquires a stock supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this chapter, may make such epinephrine auto-injectors available to individuals other than those trained individuals described in § 23-6.4-6, and such individuals may administer such epinephrine auto-injector to any individual believed in […]

Section 23-6.4-6. – Training.

§ 23-6.4-6. Training. An employee, agent, or other individual described in § 23-6.4-4 must complete an anaphylaxis training program prior to providing or administering an epinephrine auto-injector made available by an authorized entity. Such training shall be conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment, or an entity or […]

Section 23-6.4-7. – Good Samaritan protections.

§ 23-6.4-7. Good Samaritan protections. An authorized entity that possesses and makes available epinephrine auto-injectors and its employees, agents, and other trained individuals; a person who uses an epinephrine auto-injector made available pursuant to § 23-6.4-5; an authorized healthcare provider who prescribes epinephrine auto-injectors to an authorized entity; and an individual or entity that conducts […]

Section 23-6.4-8. – Reporting.

§ 23-6.4-8. Reporting. An authorized entity that possesses and makes available epinephrine auto-injectors shall submit to the department of health, on a form developed by the department of health, a report of each incident on the authorized entity’s premises that involves the administration of an epinephrine auto-injector. The department of health shall annually publish a […]